Amgen’s Amgevita, an adalimumab biosimilar to AbbVie’s Humira®, received approval from the European Commission on March 23, 2017. ...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
Amgen
-
-
Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. (collectively “Plaintiffs”) filed a Complaint in the...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Genentech’s lawsuit against Amgen has come to a quick (although perhaps temporary) end, with the Court dismissing Genentech’s complaint...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Coherus Biosciences, Inc. (“Coherus”) has filed four petitions with the Patent Trial and Appeal Board (“PTAB”) for inter partes...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]